+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Adrenergic"

Myocardial Infarction Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Myocardial Infarction Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • March 2024
  • 150 Pages
  • Global
From
Anti-Hypertensive Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 117 Pages
  • Global
From
Angina Pectoris Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Angina Pectoris Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 100 Pages
  • Global
From
Angina Pectoris Drugs Market by Type, by Drugs, by Route of Administration, by End-Users, and By Region - Product Thumbnail Image

Angina Pectoris Drugs Market by Type, by Drugs, by Route of Administration, by End-Users, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Beta blockers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Beta blockers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • February 2024
  • 185 Pages
  • Global
From
Canada Anti-Hypertensive Drugs Market Competition Forecast & Opportunities, 2028 - Product Thumbnail Image

Canada Anti-Hypertensive Drugs Market Competition Forecast & Opportunities, 2028

  • Report
  • October 2023
  • 84 Pages
  • Canada
From
Egypt Anti-Hypertensive Drugs Market, Competition, Forecast & Opportunities, 2028 - Product Thumbnail Image

Egypt Anti-Hypertensive Drugs Market, Competition, Forecast & Opportunities, 2028

  • Report
  • October 2023
  • 89 Pages
  • Egypt
From
Israel Anti-Hypertensive Drugs Market Competition Forecast & Opportunities, 2028 - Product Thumbnail Image

Israel Anti-Hypertensive Drugs Market Competition Forecast & Opportunities, 2028

  • Report
  • August 2023
  • 75 Pages
  • Israel
From
Hypertrophic Cardiomyopathy Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hypertrophic Cardiomyopathy Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 81 Pages
  • Global
From
Alpha 2C Adrenergic Receptor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Alpha 2C Adrenergic Receptor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 78 Pages
  • Global
From
Betaxolol HCl Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Betaxolol HCl Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • March 2025
  • 75 Pages
  • Global
From
Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 51 Pages
  • Global
From
Beta Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Beta Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 131 Pages
  • Global
From
Alpha Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Alpha Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 101 Pages
  • Global
From
Alpha 1A Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Alpha 1A Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 39 Pages
  • Global
From
Alpha 1B Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Alpha 1B Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 37 Pages
  • Global
From
Beta 3 Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Beta 3 Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 41 Pages
  • Global
From
Beta 2 Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Beta 2 Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 97 Pages
  • Global
From
Alpha 2 Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Alpha 2 Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 68 Pages
  • Global
From
Alpha 1 Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Alpha 1 Adrenergic Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 67 Pages
  • Global
From
Loading Indicator

The Adrenergic market within the context of Cardiovascular Drugs is a sector of the pharmaceutical industry that focuses on the development and production of drugs that act on the adrenergic receptors. These drugs are used to treat a variety of cardiovascular conditions, such as hypertension, angina, and arrhythmias. Adrenergic drugs work by stimulating the sympathetic nervous system, which increases heart rate and blood pressure. They can also be used to treat congestive heart failure, as they can help to reduce the workload of the heart. Adrenergic drugs are typically administered orally, intravenously, or intramuscularly. Common side effects of these drugs include headache, dizziness, and nausea. In some cases, they can also cause an increase in blood pressure and heart rate. Some of the companies in the Adrenergic market include Pfizer, Merck, Novartis, and GlaxoSmithKline. These companies are involved in the development and production of a variety of Adrenergic drugs, such as beta-blockers, alpha-blockers, and calcium channel blockers. Show Less Read more